{
  "symbol": "BPMC",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "precision therapy for genomically defined cancers"],
    "riskScore": 7,
    "reason": "Blueprint Medicines operates in the biotech sector, which is prone to speculation due to its focus on innovative therapies for cancer and blood disorders."
  }
}